{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:59:10Z","timestamp":1791575950823,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.jhep.2016.12.026","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T11:01:56Z","timestamp":1487934116000},"page":"942-951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["ARID2 modulates DNA damage response in human hepatocellular carcinoma cells"],"prefix":"10.1016","volume":"66","author":[{"given":"Atsushi","family":"Oba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimitsu","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketo","family":"Nishikawaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Mogushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arihiro","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Mitsunori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Asahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2016.12.026_b0005","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2016.12.026_b0010","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/ng.903","article-title":"Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma","volume":"43","author":"Li","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.12.026_b0015","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ng.2256","article-title":"Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma","volume":"44","author":"Guichard","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.12.026_b0020","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ng.2291","article-title":"Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators","volume":"44","author":"Fujimoto","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.12.026_b0025","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2016.12.026_b0030","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1038\/ncomms7120","article-title":"Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity","volume":"6","author":"Fujimoto","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2016.12.026_b0035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","article-title":"A landscape of driver mutations in melanoma","volume":"150","author":"Hodis","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2016.12.026_b0040","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1038\/ncomms4156","article-title":"Integrated analysis of germline and somatic variants in ovarian cancer","volume":"5","author":"Kanchi","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2016.12.026_b0045","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1038\/onc.2013.227","article-title":"The SWI\/SNF genetic blockade: effects in cell differentiation, cancer and developmental diseases","volume":"33","author":"Romero","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2016.12.026_b0050","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1073\/pnas.1316793111","article-title":"Functional epigenetics approach identifies BRM\/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers","volume":"111","author":"Hoffman","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2016.12.026_b0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nm.3799","article-title":"Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers","volume":"21","author":"Bitler","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2016.12.026_b0060","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/nm.3968","article-title":"SWI\/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2","volume":"21","author":"Kim","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2016.12.026_b0065","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jhep.2016.12.026_b0070","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jhep.2016.12.026_b0075","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/jnci\/djj105","article-title":"Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis","volume":"98","author":"Tanaka","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jhep.2016.12.026_b0080","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/hep.24536","article-title":"Oxidative stress pathways in noncancerous human liver tissue to predict hepatocellular carcinoma recurrence: a prospective, multicenter study","volume":"54","author":"Tanaka","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2016.12.026_b0085","doi-asserted-by":"crossref","first-page":"886","DOI":"10.18632\/oncotarget.355","article-title":"ARID2: a new tumor suppressor gene in hepatocellular carcinoma","volume":"2","author":"Zhao","year":"2011","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhep.2016.12.026_b0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccr.2013.12.007","article-title":"CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis","volume":"25","author":"Wang","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhep.2016.12.026_b0095","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1038\/sj.onc.1205743","article-title":"DNA damage, death receptor activation and reactive oxygen species contribute to ultraviolet radiation-induced apoptosis in an essential and independent way","volume":"21","author":"Kulms","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2016.12.026_b0100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/cr040483f","article-title":"Molecular mechanisms of mammalian global genome nucleotide excision repair","volume":"106","author":"Gillet","year":"2006","journal-title":"Chem Rev"},{"key":"10.1016\/j.jhep.2016.12.026_b0105","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrm3822","article-title":"Understanding nucleotide excision repair and its roles in cancer and ageing","volume":"15","author":"Marteijn","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.jhep.2016.12.026_b0110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/annonc\/mdt384","article-title":"PARP Inhibitors for BRCA1\/2 mutation-associated and BRCA-like malignancies","volume":"25","author":"Lee","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jhep.2016.12.026_b0115","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1158\/1078-0432.CCR-13-3229","article-title":"Molecular Pathways: Overcoming radiation resistance by targeting DNA damage response pathways","volume":"21","author":"Morgan","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2016.12.026_b0120","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/nsmb1152","article-title":"Rad4-Rad23 interaction with SWI\/SNF links ATP-dependent chromatin remodeling with nucleotide excision repair","volume":"13","author":"Gong","year":"2006","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.jhep.2016.12.026_b0125","doi-asserted-by":"crossref","first-page":"30424","DOI":"10.1074\/jbc.M109.044982","article-title":"Modulation of nucleotide excision repair by mammalian SWI\/SNF chromatin-remodeling complex","volume":"284","author":"Zhao","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2016.12.026_b0130","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1158\/2159-8290.CD-14-0849","article-title":"ARID1A deficiency impairs the DNA damage checkpoint and sensitizes cells to PARP inhibitors","volume":"5","author":"Shen","year":"2015","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhep.2016.12.026_b0135","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1158\/0008-5472.CAN-14-3247","article-title":"DNA damage in cancer therapeutics: a boon or a curse?","volume":"75","author":"Khanna","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2016.12.026_b0140","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nature10760","article-title":"The DNA damage response and cancer therapy","volume":"481","author":"Lord","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.12.026_b0145","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2006.07.019","article-title":"The DNA repair helicases XPD and FancJ have essential iron-sulfur domains","volume":"23","author":"Rudolf","year":"2006","journal-title":"Mol Cell"},{"key":"10.1016\/j.jhep.2016.12.026_b0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mrrev.2011.05.001","article-title":"A review and appraisal of the DNA damage theory of ageing","volume":"728","author":"Freitas","year":"2011","journal-title":"Mutat Res"},{"key":"10.1016\/j.jhep.2016.12.026_b0155","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nrd3374","article-title":"Harnessing synthetic lethal interactions in anticancer drug discovery","volume":"10","author":"Chan","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhep.2016.12.026_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2016.12.026_b0165","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature13904","article-title":"MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer","volume":"515","author":"Powles","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2016.12.026_b0170","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1200\/JCO.2013.53.0105","article-title":"Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab","volume":"32","author":"Topalian","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2016.12.026_b0175","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"371","author":"Snyder","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2016.12.026_b0180","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/j.seminoncol.2012.05.005","article-title":"Molecular targeted therapies in hepatocellular carcinoma","volume":"39","author":"Tanaka","year":"2012","journal-title":"Semin Oncol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882781730003X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882781730003X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T02:30:06Z","timestamp":1568860206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882781730003X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S016882781730003X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2016.12.026","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ARID2 modulates DNA damage response in human hepatocellular carcinoma cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2016.12.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}